Interest Coverage Ratio: 1737.00x
Is the interest coverage ratio high or low?
The interest coverage ratio of 1737.00x is 555% above its 5-year average of 265.31x, near the high end of its 5-year range (45.30x–1737.00x).
As of Saturday, June 27, 2026. 79.09% above its 12-month average of 969.93x.
WST Interest Coverage Ratio
Reported quarterly interest coverage; no daily interpolation.
WST Average Interest Coverage Ratio Chart
WST Current vs Average Interest Coverage Ratio Chart
WST Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
1737.00x
INTEREST COVERAGE RATIO AVG TTM
969.93x
INTEREST COVERAGE RATIO AVG 3Y
129.22x
INTEREST COVERAGE RATIO AVG 5Y
89.16x
INTEREST COVERAGE RATIO AVG 10Y
57.59x
INTEREST COVERAGE RATIO AVG 15Y
40.05x
INTEREST COVERAGE RATIO AVG 20Y
33.25x
CURRENT VS TTM AVG
+79.09%
CURRENT VS 3Y AVG
+1244.22%
CURRENT VS 5Y AVG
+1848.20%
CURRENT VS 10Y AVG
+2916.14%
CURRENT VS 15Y AVG
+4237.29%
CURRENT VS 20Y AVG
+5123.79%
WST Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.79B | 1737.00x | 969.93x | 129.22x | 89.16x |
| Waters Corporation (WAT)vs › | $24.41B | 12.84x | 11.03x | 12.05x | 13.28x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.54B | 16.32x | 15.71x | 16.43x | 18.17x |
| Quest Diagnostics Incorporated (DGX)vs › | $23.08B | 5.79x | 5.88x | 7.29x | 9.45x |
| BioNTech SE (BNTX)vs › | $23.07B | -45.74x | 444.02x | 1201.03x | 1201.03x |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 77.81x | 54.95x | 40.03x | 35.88x |
| Moderna, Inc. (MRNA)vs › | $26.69B | -307.40x | 531.75x | 531.75x | 531.75x |
| Incyte Corporation (INCY)vs › | $22.73B | 553.04x | 298.73x | 269.07x | 276.66x |
| DexCom, Inc. (DXCM)vs › | $27.07B | 49.83x | 40.70x | 32.97x | 24.93x |
| Labcorp Holdings Inc. (LH)vs › | $22.26B | 6.77x | 5.99x | 5.91x | 8.30x |
Financial Health Indicators
Interest Coverage
1737.0x
Debt/Equity
0.13
Current Ratio
3.02
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Interest Coverage Ratio FAQ
- What is the interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The interest coverage ratio for WST stock is 1737.00x.
- Is West Pharmaceutical Services, Inc.'s interest coverage ratio high or low?
- The interest coverage ratio of 1737.00x is 555% above its 5-year average of 265.31x, near the high end of its 5-year range (45.30x–1737.00x).
- What is the TTM average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The TTM average interest coverage ratio for WST stock is 969.93x.
- What is the 3Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The 3Y average interest coverage ratio for WST stock is 129.22x.
- What is the 5Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The 5Y average interest coverage ratio for WST stock is 89.16x.
- What is the 10Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The 10Y average interest coverage ratio for WST stock is 57.59x.
- What is the 15Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The 15Y average interest coverage ratio for WST stock is 40.05x.
- What is the 20Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
- The 20Y average interest coverage ratio for WST stock is 33.25x.
WST Interest Coverage Ratio History
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | 1737.00x |
| 2025-06-30 | 1582.00x |
| 2025-03-31 | 321.00x |
| 2024-09-30 | 239.71x |
| 2024-06-30 | 87.20x |
| 2024-03-31 | 84.67x |
| 2023-12-31 | 155.09x |
| 2023-09-30 | 65.90x |
| 2023-06-30 | 72.04x |
| 2023-03-31 | 76.14x |
| 2022-12-31 | 101.13x |
| 2022-09-30 | 89.33x |
| 2022-06-30 | 124.39x |
| 2022-03-31 | 88.95x |
| 2021-12-31 | 58.35x |
| 2021-09-30 | 107.94x |
| 2021-06-30 | 116.61x |
| 2021-03-31 | 100.17x |
| 2020-12-31 | 45.30x |
| 2020-09-30 | 53.35x |
| 2020-06-30 | 56.95x |
| 2020-03-31 | 42.25x |
| 2019-12-31 | 41.26x |
| 2019-09-30 | 36.60x |
| 2019-06-30 | 40.84x |
| 2019-03-31 | 30.95x |
| 2018-12-31 | 39.55x |
| 2018-09-30 | 28.47x |
| 2018-06-30 | 24.82x |
| 2018-03-31 | 27.28x |
| 2017-12-31 | 28.62x |
| 2017-09-30 | 41.09x |
| 2017-06-30 | 27.00x |
| 2017-03-31 | 34.22x |
| 2016-12-31 | 60.00x |
| 2016-09-30 | 29.56x |
| 2016-06-30 | 30.60x |
| 2016-03-31 | 12.00x |
| 2015-12-31 | 15.59x |
| 2015-09-30 | -0.95x |
| 2015-06-30 | 11.50x |
| 2015-03-31 | 11.66x |
| 2014-12-31 | 11.74x |
| 2014-09-30 | 9.78x |
| 2014-06-30 | 12.88x |
| 2014-03-31 | 9.82x |
| 2013-12-31 | 9.46x |
| 2013-09-30 | 9.02x |
| 2013-06-30 | 10.37x |
| 2013-03-31 | 9.41x |
| 2012-12-31 | 9.00x |
| 2012-09-30 | 5.98x |
| 2012-06-30 | 7.74x |
| 2012-03-31 | 9.70x |
| 2011-12-31 | 6.14x |
| 2011-09-30 | 5.80x |
| 2011-06-30 | 6.04x |
| 2011-03-31 | 6.13x |
| 2010-12-31 | 1.26x |
| 2010-09-30 | 6.02x |
| 2010-06-30 | 7.82x |
| 2010-03-31 | 7.22x |
| 2009-12-31 | 5.29x |
| 2009-09-30 | 6.82x |
| 2009-06-30 | 8.17x |
| 2009-03-31 | 5.44x |
| 2008-09-30 | 4.16x |
| 2008-08-05 | 10.14x |
| 2008-03-31 | 9.29x |
| 2006-03-31 | 9.40x |
| 2005-06-30 | 6.86x |
| 2005-03-31 | 10.05x |
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green